CREDIT SUISSE AG/ - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 129 filers reported holding CYTOMX THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$0
-100.0%
35
-99.9%
0.00%
Q3 2021$153,000
-47.1%
30,179
-34.0%
0.00%
Q2 2021$289,000
-11.1%
45,723
+8.9%
0.00%
Q1 2021$325,000
-54.2%
42,005
-61.2%
0.00%
Q4 2020$709,000
-23.0%
108,176
-21.9%
0.00%
-100.0%
Q3 2020$921,000
-41.0%
138,587
-26.1%
0.00%0.0%
Q2 2020$1,562,000
+69.6%
187,461
+56.1%
0.00%0.0%
Q1 2020$921,000
-11.8%
120,126
-4.5%
0.00%0.0%
Q4 2019$1,044,000
+57.9%
125,761
+40.4%
0.00%0.0%
Q3 2019$661,000
+63.6%
89,570
+148.2%
0.00%
Q2 2019$404,000
-26.9%
36,092
-29.8%
0.00%
-100.0%
Q1 2019$553,000
+12.9%
51,392
+58.2%
0.00%0.0%
Q4 2018$490,000
-29.6%
32,491
-13.6%
0.00%0.0%
Q3 2018$696,000
-18.4%
37,621
+0.9%
0.00%0.0%
Q2 2018$853,000
-37.0%
37,300
-21.6%
0.00%0.0%
Q1 2018$1,354,000
+94.3%
47,595
+44.0%
0.00%0.0%
Q4 2017$697,000
+56.6%
33,046
+34.8%
0.00%
Q3 2017$445,000
+220.1%
24,522
+92.6%
0.00%
Q4 2016$139,000
-51.4%
12,735
-30.3%
0.00%
Q3 2016$286,000
+101.4%
18,265
+31.6%
0.00%
Q2 2016$142,00013,8770.00%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 524,763$7,924,0003.84%
Congress Park Capital LLC 123,311$1,862,0002.05%
Perceptive Advisors 2,911,715$43,588,0001.66%
RTW INVESTMENTS, LP 908,586$13,720,0001.28%
HAMILTON LANE ADVISORS LLC 68,753$1,038,0000.91%
HARBOURVEST PARTNERS LLC 79,193$1,196,0000.57%
SPHERA FUNDS MANAGEMENT LTD. 273,151$4,125,0000.46%
Exane Asset Management 50,000$755,000,0000.44%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 622,548$9,400,0000.38%
Cormorant Asset Management, LP 296,712$4,480,0000.36%
View complete list of CYTOMX THERAPEUTICS INC shareholders